Medite Cancer Diagnostics, Inc. (MDIT)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 5, 2025
Medite Cancer Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | 2012 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '18 Sep 30, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | 2012 |
| Revenue | 8.13 | 6.81 | 9.24 | 9.89 | 10.98 | 9.96 | Upgrade
|
| Revenue Growth (YoY) | 19.50% | -26.25% | -6.56% | -9.98% | 10.29% | 4.22% | Upgrade
|
| Cost of Revenue | 6.21 | 6.65 | 5.61 | 6.08 | 7.16 | 5.75 | Upgrade
|
| Gross Profit | 1.93 | 0.16 | 3.63 | 3.8 | 3.82 | 4.21 | Upgrade
|
| Selling, General & Admin | 4.94 | 5.16 | 3.6 | 2.95 | 2.8 | 2.78 | Upgrade
|
| Research & Development | 0.72 | 1.19 | 1.48 | 1.28 | 1.24 | 0.93 | Upgrade
|
| Operating Expenses | 5.94 | 6.64 | 5.29 | 4.4 | 4.21 | 3.92 | Upgrade
|
| Operating Income | -4.01 | -6.48 | -1.66 | -0.6 | -0.39 | 0.29 | Upgrade
|
| Interest Expense | -2.03 | -0.85 | -0.69 | -0.2 | -0.28 | -0.31 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.23 | 0.19 | 0.06 | 0.02 | 0.08 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -5.81 | -7.14 | -2.3 | -0.78 | -0.6 | 0.07 | Upgrade
|
| Other Unusual Items | - | -0.16 | - | - | - | - | Upgrade
|
| Pretax Income | -5.81 | -7.3 | -2.3 | -0.78 | -0.6 | 0.07 | Upgrade
|
| Income Tax Expense | -0.49 | -0.49 | -0.13 | 0.08 | 0.1 | 0.02 | Upgrade
|
| Net Income | -5.33 | -6.81 | -2.16 | -0.86 | -0.7 | 0.05 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.09 | 0.09 | 0.09 | 0.08 | 0.11 | - | Upgrade
|
| Net Income to Common | -5.42 | -6.9 | -2.25 | -0.94 | -0.81 | 0.05 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 54.29% | Upgrade
|
| Shares Outstanding (Basic) | 49 | 26 | 21 | 20 | 18 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 49 | 26 | 21 | 20 | 18 | 15 | Upgrade
|
| Shares Change (YoY) | 99.94% | 23.40% | 6.08% | 11.47% | 23.34% | - | Upgrade
|
| EPS (Basic) | -0.11 | -0.26 | -0.11 | -0.05 | -0.04 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.26 | -0.11 | -0.05 | -0.04 | 0.00 | Upgrade
|
| Free Cash Flow | -5.3 | -3.7 | -1.21 | -0.6 | -1.35 | -0.5 | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.14 | -0.06 | -0.03 | -0.07 | -0.03 | Upgrade
|
| Gross Margin | 23.71% | 2.38% | 39.29% | 38.46% | 34.77% | 42.30% | Upgrade
|
| Operating Margin | -49.34% | -95.11% | -17.98% | -6.06% | -3.59% | 2.95% | Upgrade
|
| Profit Margin | -66.61% | -101.31% | -24.40% | -9.48% | -7.36% | 0.54% | Upgrade
|
| Free Cash Flow Margin | -65.13% | -54.35% | -13.05% | -6.03% | -12.33% | -5.01% | Upgrade
|
| EBITDA | -3.73 | -6.19 | -1.45 | -0.42 | -0.22 | 0.5 | Upgrade
|
| EBITDA Margin | -45.89% | -90.81% | -15.66% | -4.27% | -2.04% | 4.98% | Upgrade
|
| D&A For EBITDA | 0.28 | 0.29 | 0.21 | 0.18 | 0.17 | 0.2 | Upgrade
|
| EBIT | -4.01 | -6.48 | -1.66 | -0.6 | -0.39 | 0.29 | Upgrade
|
| EBIT Margin | -49.34% | -95.11% | -17.98% | -6.06% | -3.59% | 2.95% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 26.03% | Upgrade
|
| Advertising Expenses | - | 0.17 | 0.05 | 0.05 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.